Retinopathy of prematurity (ROP) is the interruption of the physiological development of retinal vascularization due to preterm delivery and is a proliferative vitreoretinopathy characterized by an evolving pathological process. Many innovations have emerged in the naming, screening, follow-up, and treatment of the disease in the 70 years since then first defined by Terry. This review is an examination of this difficult and dynamic area of modern-day ophthalmology practice in the light of current information.
Keywords: Plus disease, prematurity, threshold disease.